Other Non-Executive Director Choo Yeon-sung Exercises Stock Purchase Right, Increasing Shareholding in Curacle

Digital Today Editor Kim Joo-hoon reports that Choo Yeon-sung, an Other Non-Executive Director of Curacle (365270), exercised stock purchase rights, acquiring 10,000 ordinary shares as of June 8. This increased his shareholding ratio to 0.05%. The transaction was executed at a price of 6,209 won per share, adding 10,000 shares to his holdings. As of 2:10 PM on June 10, Curacle's stock closed at 11,080 won, down 360 won from the previous day. Recent financials show total assets of 532 billion won, liabilities of 161 billion won, and equity of 371 billion won. The company reported revenue of 710 million won, an operating loss of 165 billion won, and a net loss of 181 billion won. Curacle, a natural science and engineering R&D firm listed on KOSDAQ since May 12, 2016, is a 12-month fiscal year company.